新田ゼラチン(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 化学 | 4977/E26061 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2017/03/17 | 日証協 | 239,500株 | +23.01% | 139,000株 | +101.16% | 289,209株 | +13.29% | 21,830株 | -35.93% |
| 2017/03/10 | 日証協 | 194,700株 | -0.56% | 69,100株 | +299.42% | 255,271株 | -0.35% | 34,070株 | +5.79% |
| 2017/03/03 | 日証協 | 195,800株 | +8.9% | 17,300株 | +12.34% | 256,166株 | +4.99% | 32,205株 | +86.05% |
| 2017/02/24 | 日証協 | 179,800株 | +9.23% | 15,400株 | +37.5% | 243,985株 | -1.53% | 17,310株 | +332.75% |
| 2017/02/17 | 日証協 | 164,600株 | -1.56% | 11,200株 | 0% | 247,775株 | -1.71% | 4,000株 | +300% |
| 2017/02/10 | 日証協 | 167,200株 | +0.24% | 11,200株 | +16.67% | 252,088株 | -1.14% | 1,000株 | -77.78% |
| 2017/02/03 | 日証協 | 166,800株 | +5.5% | 9,600株 | -58.08% | 254,988株 | +10.34% | 4,500株 | +28.57% |
| 2017/01/27 | 日証協 | 158,100株 | -4.93% | 22,900株 | +9999.99% | 231,088株 | -7.97% | 3,500株 | +84.21% |
| 2017/01/20 | 日証協 | 166,300株 | -0.19% | 200株 | -97.67% | 251,088株 | +0.72% | 1,900株 | -70.31% |
| 2017/01/13 | 日証協 | 166,614株 | -0.88% | 8,600株 | +2766.67% | 249,302株 | +6.91% | 6,400株 | +156% |
| 2017/01/06 | 日証協 | 168,100株 | -6.14% | 300株 | -92.11% | 233,188株 | -7.02% | 2,500株 | -56.15% |
| 2016/12/30 | 日証協 | 179,100株 | -1% | 3,800株 | -73.97% | 250,787株 | -3.24% | 5,701株 | +533.44% |
| 2016/12/22 | 日証協 | 180,900株 | +4.75% | 14,600株 | +180.77% | 259,188株 | +8.14% | 900株 | -68.97% |
| 2016/12/16 | 日証協 | 172,700株 | -4.9% | 5,200株 | +1200% | 239,688株 | -7.77% | 2,900株 | +52.63% |
| 2016/12/09 | 日証協 | 181,600株 | +0.22% | 400株 | -96.19% | 259,888株 | -0.27% | 1,900株 | -44.12% |
| 2016/12/02 | 日証協 | 181,200株 | +6.03% | 10,500株 | -15.32% | 260,588株 | +3.78% | 3,400株 | -69.09% |
| 2016/11/25 | 日証協 | 170,900株 | -4.04% | 12,400株 | -15.65% | 251,088株 | -2.71% | 11,000株 | +89.66% |
| 2016/11/18 | 日証協 | 178,100株 | -0.84% | 14,700株 | +66.65% | 258,088株 | -0.27% | 5,800株 | +11.54% |
| 2016/11/11 | 日証協 | 179,600株 | -11.95% | 8,821株 | +395.84% | 258,788株 | -6.1% | 5,200株 | +20.93% |
※株式分割は考慮していませんのでご注意ください。
Page Top